細胞環境を最適化する遺伝的改良 (Genetic Tweak Optimizes Drug-making Cells by Blocking Buildup of Toxic Byproduct)

ad

2025-01-14 カリフォルニア大学サンディエゴ校(UCSD)

UCサンディエゴの研究者たちは、CHO細胞(薬剤製造に広く使用される細胞)において乳酸の生成を抑制する新しい遺伝子改変手法を開発しました。この手法により、乳酸蓄積による毒性を回避しつつ、薬剤生産量を大幅に向上させることが可能になりました。特に、抗がん剤や抗体薬の生産効率が向上し、製造コスト削減が期待されています。この研究は、細胞のエネルギー代謝に関する従来の理論にも挑戦し、産業応用の可能性を広げています。

<関連情報>

マルチプレックスゲノム編集により、哺乳類細胞の増殖速度に影響を与えることなく乳酸産生が除去される Multiplex genome editing eliminates lactate production without impacting growth rate in mammalian cells

Hooman Hefzi,Iván Martínez-Monge,Igor Marin de Mas,Nicholas Luke Cowie,Alejandro Gomez Toledo,Soo Min Noh,Karen Julie la Cour Karottki,Marianne Decker,Johnny Arnsdorf,Jose Manuel Camacho-Zaragoza,Stefan Kol,Sanne Schoffelen,Nuša Pristovšek,Anders Holmgaard Hansen,Antonio A. Miguez,Sara Petersen Bjørn,Karen Kathrine Brøndum,Elham Maria Javidi,Kristian Lund Jensen,Laura Stangl,Emanuel Kreidl,Thomas Beuchert Kallehauge,Daniel Ley,Patrice Ménard,… Nathan E. Lewis
Nature Metabolism  Published:14 January 2025
DOI:https://doi.org/10.1038/s42255-024-01193-7

細胞環境を最適化する遺伝的改良 (Genetic Tweak Optimizes Drug-making Cells by Blocking Buildup of Toxic Byproduct)

Abstract

The Warburg effect, which describes the fermentation of glucose to lactate even in the presence of oxygen, is ubiquitous in proliferative mammalian cells, including cancer cells, but poses challenges for biopharmaceutical production as lactate accumulation inhibits cell growth and protein production. Previous efforts to eliminate lactate production in cells for bioprocessing have failed as lactate dehydrogenase is essential for cell growth. Here, we effectively eliminate lactate production in Chinese hamster ovary and in the human embryonic kidney cell line HEK293 by simultaneous knockout of lactate dehydrogenases and pyruvate dehydrogenase kinases, thereby removing a negative feedback loop that typically inhibits pyruvate conversion to acetyl-CoA. These cells, which we refer to as Warburg-null cells, maintain wild-type growth rates while producing negligible lactate, show a compensatory increase in oxygen consumption, near total reliance on oxidative metabolism, and higher cell densities in fed-batch cell culture. Warburg-null cells remain amenable for production of diverse biotherapeutic proteins, reaching industrially relevant titres and maintaining product glycosylation. The ability to eliminate lactate production may be useful for biotherapeutic production and provides a tool for investigating a common metabolic phenomenon.

有機化学・薬学
ad
ad
Follow
ad
タイトルとURLをコピーしました